+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Plasma Fractionation: Global Markets

  • ID: 5205803
  • Report
  • November 2020
  • Region: Global
  • 125 pages
  • BCC Research
1 of 3

FEATURED COMPANIES

  • Adma Biologics Inc.
  • Baxter
  • Csl Ltd.
  • Grifols S.A.
  • Kedrion Spa
  • Octapharma Ag
  • MORE
Report Scope:

The current report offers a detailed picture of the market for plasma fractionation.

This report highlights the current and future market potential for plasma fractionation and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players.

This report details market shares for plasma fractionation based on product, application, end user and geography. Based on product, the market is segmented into immunoglobulins, albumins, coagulation factor concentrates and other segments. Based on application, the market is segmented into neurology, immunology, hematology and others. Based on end user, the market segmented into hospitals and clinics, research laboratories and others.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2020 through 2025. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:
  • 27 data tables and 25 additional tables
  • Comprehensive overview of the global markets for plasma fractionation and its sub-segments
  • Analyses of the global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Estimation of the actual market size and revenue forecasts for plasma fractionation, and market share analysis on the basis of product type, application, end user and geographical region
  • Country specific data and analysis of the U.S., Canada, France, Germany, U.K., Italy, Spain, Australia, India, Japan, China and other emerging economies from the Latin America and MEA regions
  • Insights into the market potential for plasma fractionation, opportunities and restraints, regulatory updates, and technological trends and issues impacting the industry
  • Impact analysis of COVID-19 pandemic on the growth of plasma fractionation industry vs. its impact on social and geopolitical spheres
  • Porter’s Five Forces analysis of the market for plasma fractionation and global company ranking within the market
  • Profile descriptions of the market leading participants, including ADMA Biologics Inc., Baxter International Inc., China Biologic Products Holdings Inc., CSL Ltd., and Grifols, S.A.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Adma Biologics Inc.
  • Baxter
  • Csl Ltd.
  • Grifols S.A.
  • Kedrion Spa
  • Octapharma Ag
  • MORE
Chapter 1 Introduction
  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports
Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background
  • Overview of Plasma Fractionation
  • Classic Fractionation Methods (Cohn Fractionation)
  • Components of Blood Plasma
  • Functions of Blood Plasma
  • Blood Donation
  • Collection and Extraction of Blood Plasma
  • Fractionation Methods for Extracting Individual Components of Plasma
  • Government Funding of Blood Donation Facilities
  • Government Regulations: FDA, International Regulatory Agencies and Medical Associations
  • Clinical Guidelines
Chapter 4 Impact of COVID-19
  • Introduction
  • Outbreak
  • Progression of COVID-19
  • Government Expenditures on COVID-19
  • Social Impact of COVID-19
  • Impact on Insurance Providers
  • Impact on Health Technology Assessment
Chapter 5 Market Dynamics
  • Market Drivers
  • Overview
  • Growing Use of Immunoglobulins in Various Therapeutic Areas
  • Growing Prevalence of Alpha-1 Antitrypsin Deficiency (AATD) and Respiratory Diseases
  • Growing Geriatric Population
  • Increase in Blood Donations
  • Market Restraints
  • High Costs Associated with Plasma Therapies
  • Stringent Government Regulations and Low Reimbursement Policies
  • Market Opportunities
  • Opportunities in Emerging Nations
Chapter 6 Market Breakdown by Product
  • Global Market for Plasma Fractionation by Product
  • Immunoglobulins
  • Albumins
  • Coagulation Factor Concentrates
  • Others
Chapter 7 Market Breakdown by Application
  • Global Plasma Fractionation Market by Application
  • Neurology
  • Immunology
  • Hematology
  • Others
Chapter 8 Market Breakdown by End User
  • Global Plasma Fractionation Market by End User
  • Hospitals and Clinics
  • Research Laboratories
  • Others
Chapter 9 Market Breakdown by Region
  • Global Market for Plasma Fractionation by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
Chapter 10 Competitive Landscape
  • Global Company Ranking
  • Porter's Five Forces Analysis
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Threat of Substitutes
  • Competitive Rivalry/Degree of Competition
Chapter 11 Company Profiles
  • ADMA Biologics Inc.
  • Baxter
  • China Biologic Products Inc.
  • Csl Ltd.
  • Grifols S.A.
  • Kedrion Spa
  • Octapharma Ag
List of Tables
Summary Table A: Global Market for Plasma Fractionation, by Product, Through 2025
Summary Table B: Global Market for Plasma Fractionation, by Application, Through 2025
Table 1: Blood Plasma Components
Table 2: Plasma Constituents and Their Function
Table 3: Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method
Table 4: Expenditures on COVID-19 Crisis, by Country
Table 5: Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
Table 6: Use of Immunoglobulin in Hematology
Table 7: Use of Immunoglobulin in Neurology
Table 8: Use of Immunoglobulin in Infectious Diseases
Table 9: Use of Immunoglobulin in Neurology
Table 10: Number and Distribution of Persons Aged 60 and Over, by Region, 2017 and 2050
Table 11: Global Market for Plasma Fractionation, by Product, Through 2025
Table 12: Global Market for Plasma Fractionation of Immunoglobulins, by Region, Through 2025
Table 13: Albumin Products, by Company
Table 14: Global Market for Plasma Fractionation of Albumin, by Region, Through 2025
Table 15: Global Market for Plasma Fractionation of Coagulation Factor Concentrates, by Region, Through 2025
Table 16: Global Market for Plasma Fractionation of Other Products, by Region, Through 2025
Table 17: Global Market for Plasma Fractionation, by Application, Through 2025
Table 18: Global Market for Plasma Fractionation in Neurology, by Region, Through 2025
Table 19: Global Market for Plasma Fractionation in Immunology, by Region, Through 2025
Table 20: Global Market for Plasma Fractionation in Hematology, by Region, Through 2025
Table 21: Global Market for Plasma Fractionation of Other Applications, by Region, Through 2025
Table 22: Global Market for Plasma Fractionation, by End User, Through 2025
Table 23: Global Market for Plasma Fractionation in Hospital and Clinics, by Region, Through 2025
Table 24: Global Market for Plasma Fractionation in Research Laboratories, by Region, Through 2025
Table 25: Global Market for Plasma Fractionation Used by Other End Users, by Region, Through 2025
Table 26: Global Market for Plasma Fractionation, by Region, Through 2025
Table 27: North American Market for Plasma Fractionation, by Product, Through 2025
Table 28: North American Market for Plasma Fractionation, by Country, Through 2025
Table 29: European Market for Plasma Fractionation, by Product, Through 2025
Table 30: European Market for Plasma Fractionation, by Country/Region, Through 2025
Table 31: Asia-Pacific Market for Plasma Fractionation, by Product, Through 2025
Table 32: Asia-Pacific Market for Plasma Fractionation, by Country/Region, Through 2025
Table 33: Japanese Market Statistics
Table 34: Latin American Market for Plasma Fractionation, by Product, Through 2025
Table 35: Middle Eastern and African Market for Plasma Fractionation, by Product, Through 2025
Table 36: Global Company Ranking in the Market for Plasma Fractionation, 2019
Table 37: Porter's Five Forces Analysis
Table 38: ADMA Biologics Inc.: Products and Services
Table 39: ADMA Biologics Inc.: Recent Developments, 2017-2020
Table 40: Baxter: Products and Services
Table 41: China Biologic Products Holdings Inc.: Products and Services
Table 42: China Biologic Products Holdings Inc.: Pipeline Plasma Products
Table 43: China Biologic Products Holdings Inc.: Recent Developments, 2017
Table 44: CSL Ltd.: Products and Services
Table 45: CSL Ltd.: Recent Developments, 2017-2020
Table 46: Grifols, S.A.: Products and Services
Table 47: Grifols, S.A..: Recent Developments, 2017-2020
Table 48: Kedrion SpA: Products and Services
Table 49: Kedrion SpA: Recent Developments, 2017-2020
Table 50: Octapharma AG: Products and Services
Table 51: Octapharma AG: Recent Developments, 2020

List of Figures
Summary Figure A: Global Market Shares for Plasma Fractionation, by Product, 2019
Summary Figure B: Global Market Shares for Plasma Fractionation, by Application, 2019
Figure 1: Comparison of GDP Growth, by Countries, 2019 and 2020
Figure 2: FDA Regulation for Approval of Blood Products and Devices
Figure 3: Global Market Shares for Plasma Fractionation, by Product, 2019
Figure 4: Immunoglobulin Products
Figure 5: Categorization of Subcutaneous Immunoglobulin
Figure 6: Global Market for Plasma Fractionation of Immunoglobulins, 2018-2025
Figure 7: Global Market for Plasma Fractionation of Immunoglobulins, by Region, 2018-2025
Figure 8: Global Market for Plasma Fractionation of Albumin, 2018-2025
Figure 9: Global Market for Plasma Fractionation of Albumin, by Region, 2018-2025
Figure 10: Global Market for Plasma Fractionation of Coagulation Factor Concentrates, 2018-2025
Figure 11: Global Market for Plasma Fractionation of Coagulation Factor Concentrates, by Region, 2018-2025
Figure 12: Global Market for Plasma Fractionation of Other Products, 2018-2025
Figure 13: Global Market for Plasma Fractionation of Other Products, by Region, 2018-2025
Figure 14: Global Market Shares for Plasma Fractionation, by Application, 2019
Figure 15: Global Market for Plasma Fractionation in Neurology, 2018-2025
Figure 16: Global Market for Plasma Fractionation in Neurology, by Region, 2018-2025
Figure 17: Global Market for Plasma Fractionation in Immunology, 2018-2025
Figure 18: Global Market for Plasma Fractionation in Immunology, by Region, 2018-2025
Figure 19: Global Market for Plasma Fractionation in Hematology, 2018-2025
Figure 20: Global Market for Plasma Fractionation in Hematology, by Region, 2018-2025
Figure 21: Global Market for Plasma Fractionation of Other Applications, 2018-2025
Figure 22: Global Market for Plasma Fractionation of Other Applications, by Region, 2018-2025
Figure 23: Global Market Shares for Plasma Fractionation, by End User, 2019
Figure 24: Global Market for Plasma Fractionation in Hospital and Clinics, 2018-2025
Figure 25: Global Market for Plasma Fractionation in Hospital and Clinics, by Region, 2018-2025
Figure 26: Global Market for Plasma Fractionation in Research Laboratories, 2018-2025
Figure 27: Global Market for Plasma Fractionation in Research Laboratories, by Region, 2018-2025
Figure 28: Role of Platelet-Rich Plasma in Treatment
Figure 29: Global Market for Plasma Fractionation Used by Other End Users, 2018-2025
Figure 30: Global Market for Plasma Fractionation Used by Other End Users, by Region, 2018-2025
Figure 31: Global Market for Plasma Fractionation, by Region, 2018-2025
Figure 32: Global Market Shares for Plasma Fractionation, by Region, 2019
Figure 33: North American Market Shares for Plasma Fractionation, by Product, 2019
Figure 34: North American Market Shares for Plasma Fractionation, by Country, 2019
Figure 35: U.S. Market for Plasma Fractionation, 2019-2025
Figure 36: Canadian Market for Plasma Fractionation, 2019-2025
Figure 37: European Market Shares for Plasma Fractionation, by Product, 2019
Figure 38: European Market Shares for Plasma Fractionation, by Country/Region, 2019
Figure 39: German Market for Plasma Fractionation, 2019-2025
Figure 40: French Market for Plasma Fractionation, 2019-2025
Figure 41: U.K. Market for Plasma Fractionation, 2019-2025
Figure 42: Italian Market for Plasma Fractionation, 2019-2025
Figure 43: Spanish Market for Plasma Fractionation, 2019-2025
Figure 44: Rest of European Market for Plasma Fractionation, 2019-2025
Figure 45: Asia-Pacific Market Shares for Plasma Fractionation, by Product, 2019
Figure 46: Asia-Pacific Market Shares for Plasma Fractionation, by Country/Region, 2019
Figure 47: Chinese Market for Plasma Fractionation, 2019-2025
Figure 48: Japanese Market for Plasma Fractionation, 2019-2025
Figure 49: Indian Market for Plasma Fractionation, 2019-2025
Figure 50: Australian Market for Plasma Fractionation, 2019-2025
Figure 51: South Korean Market for Plasma Fractionation, 2019-2025
Figure 52: Rest of Asia-Pacific Market for Plasma Fractionation, 2019-2025
Figure 53: Latin American Market for Plasma Fractionation, 2019-2025
Figure 54: Latin American Market Shares for Plasma Fractionation, by Product, 2019
Figure 55: Middle Eastern and African Market for Plasma Fractionation, 2019-2025
Figure 56: Middle Eastern and African Market Shares for Plasma Fractionation, by Product, 2019
Figure 57: ADMA Biologics Inc.: Financials, 2015-2019
Figure 58: ADMA Biologics Inc.: Revenue Share, by Business Segment, 2019
Figure 59: Baxter: Annual Revenue, 2015-2019
Figure 60: Baxter: Revenue Share, by Business Unit, 2019
Figure 61: Baxter: Revenue Share, by Region, 2019
Figure 62: China Biologic Products Holdings Inc.: Financials, 2015-2019
Figure 63: China Biologic Products Holdings Inc.: Revenue Share, by Segment, 2019
Figure 64: CSL Ltd.: Financials, 2015-2019
Figure 65: CSL Ltd.: Revenue Share, by Segment, 2019
Figure 66: CSL Ltd.: Revenue Share, by Country/Region, 2019
Figure 67: Grifols S.A.: Financials, 2015-2019
Figure 68: Grifols S.A.: Revenues Share, by Segment, 2019
Figure 69: Grifols S.A.: Revenue Share, by Country/Region, 2019
Figure 70: Kedrion SpA: Financials, 2015-2019
Figure 71: Kedrion SpA: Revenue Share, by Segment, 2019
Figure 72: Kedrion SpA: Revenue Share, by Country/Region, 2019
Figure 73: Octapharma AG: Financials, 2015-2019
Figure 74: Octapharma AG: Revenue, by Operating Income, 2015-2019
Note: Product cover images may vary from those shown
3 of 3
  • Adma Biologics Inc.
  • Baxter
  • China Biologic Products Inc.
  • Csl Ltd.
  • Grifols S.A.
  • Kedrion Spa
  • Octapharma Ag
Note: Product cover images may vary from those shown
Adroll
adroll